Plain-English translation of NCT07235410 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing a computer program that analyzes CT scan images to better predict how patients with liver cancer will respond to a treatment called TACE (transarterial chemoembolization). By measuring details about your organs and tissues on these routine scans, the program aims to help doctors understand your overall health and estimate your chances of survival after treatment.
Currently, doctors cannot easily predict which patients will benefit most from TACE treatment — some patients respond very well while others do not. This study exists to create a prediction tool that could help doctors personalize treatment plans and improve outcomes for liver cancer patients who cannot have surgery.
You likely qualify if…
You likely don't qualify if…
This is not an intervention study — researchers will analyze CT scans you've already had or will have as part of your regular cancer care. You will not receive any new medication or procedure. The study involves allowing researchers to use your medical images and records to train and test their artificial intelligence prediction model, with follow-up to track your treatment outcomes over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China